Vor Biopharma Inc. (VOR) stock
VORNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 5/30
$17.83−0.35 (-1.93%)
Close on Nov 18, 2026Market cap $1.10BP/E –Yield –
Vor Biopharma price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Vor Biopharma's price to book ratio was 3.9× on Jul 31, 2025, against 0.5× a year earlier. Over the last 4 years it ranged from 0.4× to 3.9×, with a median of 1.0×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2025 | Jul 31, 2025 | 3.9× | +2.9 |
| 2024 | Dec 31, 2024 | 1.0× | +0.2 |
| 2023 | Dec 29, 2023 | 0.9× | −0.7 |
| 2022 | Dec 30, 2022 | 1.6× | −0.2 |
| 2021 | Dec 31, 2021 | 1.8× | – |
See a number that looks wrong?